Medical Care
Global Cancer Hormone Therapy Drugs Market Research Report 2024
- Mar 13, 24
- ID: 121011
- Pages: 88
- Figures: 162
- Views: 29
Hormone Therapy, (also called hormonal therapy, hormone treatment, or endocrine therapy) is a cancer treatment that blocks or lowers the growth of cancer that uses hormones to grow. Doctors use it to treat some cancers such as breast and prostate cancer.
The global Cancer Hormone Therapy Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Cancer Hormone Therapy Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Cancer Hormone Therapy Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Cancer Hormone Therapy Drugs in Breast Cancer is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Cancer Hormone Therapy Drugs include Roche, Amgen, Pfizer, Teva, Takeda, Samyang Biopharmaceuticals, Tolmar, AstraZeneca and Novartis, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cancer Hormone Therapy Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Hormone Therapy Drugs.
Report Scope
The Cancer Hormone Therapy Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cancer Hormone Therapy Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cancer Hormone Therapy Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Amgen
Pfizer
Teva
Takeda
Samyang Biopharmaceuticals
Tolmar
AstraZeneca
Novartis
Aspen
Segment by Type
Tamoxifen
Aromatase Inhibitors
Antiandrogens
Androgen Synthesis Inhibitors
Other
Segment by Application
Breast Cancer
Prostate Cancer
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Hormone Therapy Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Cancer Hormone Therapy Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Cancer Hormone Therapy Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Cancer Hormone Therapy Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Cancer Hormone Therapy Drugs in Breast Cancer is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Cancer Hormone Therapy Drugs include Roche, Amgen, Pfizer, Teva, Takeda, Samyang Biopharmaceuticals, Tolmar, AstraZeneca and Novartis, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cancer Hormone Therapy Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Hormone Therapy Drugs.
Report Scope
The Cancer Hormone Therapy Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cancer Hormone Therapy Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cancer Hormone Therapy Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Amgen
Pfizer
Teva
Takeda
Samyang Biopharmaceuticals
Tolmar
AstraZeneca
Novartis
Aspen
Segment by Type
Tamoxifen
Aromatase Inhibitors
Antiandrogens
Androgen Synthesis Inhibitors
Other
Segment by Application
Breast Cancer
Prostate Cancer
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Hormone Therapy Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Hormone Therapy Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Tamoxifen
1.2.3 Aromatase Inhibitors
1.2.4 Antiandrogens
1.2.5 Androgen Synthesis Inhibitors
1.2.6 Other
1.3 Market by Application
1.3.1 Global Cancer Hormone Therapy Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Breast Cancer
1.3.3 Prostate Cancer
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Hormone Therapy Drugs Market Perspective (2019-2030)
2.2 Cancer Hormone Therapy Drugs Growth Trends by Region
2.2.1 Global Cancer Hormone Therapy Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cancer Hormone Therapy Drugs Historic Market Size by Region (2019-2024)
2.2.3 Cancer Hormone Therapy Drugs Forecasted Market Size by Region (2025-2030)
2.3 Cancer Hormone Therapy Drugs Market Dynamics
2.3.1 Cancer Hormone Therapy Drugs Industry Trends
2.3.2 Cancer Hormone Therapy Drugs Market Drivers
2.3.3 Cancer Hormone Therapy Drugs Market Challenges
2.3.4 Cancer Hormone Therapy Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Hormone Therapy Drugs Players by Revenue
3.1.1 Global Top Cancer Hormone Therapy Drugs Players by Revenue (2019-2024)
3.1.2 Global Cancer Hormone Therapy Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Cancer Hormone Therapy Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cancer Hormone Therapy Drugs Revenue
3.4 Global Cancer Hormone Therapy Drugs Market Concentration Ratio
3.4.1 Global Cancer Hormone Therapy Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Hormone Therapy Drugs Revenue in 2023
3.5 Cancer Hormone Therapy Drugs Key Players Head office and Area Served
3.6 Key Players Cancer Hormone Therapy Drugs Product Solution and Service
3.7 Date of Enter into Cancer Hormone Therapy Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Hormone Therapy Drugs Breakdown Data by Type
4.1 Global Cancer Hormone Therapy Drugs Historic Market Size by Type (2019-2024)
4.2 Global Cancer Hormone Therapy Drugs Forecasted Market Size by Type (2025-2030)
5 Cancer Hormone Therapy Drugs Breakdown Data by Application
5.1 Global Cancer Hormone Therapy Drugs Historic Market Size by Application (2019-2024)
5.2 Global Cancer Hormone Therapy Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cancer Hormone Therapy Drugs Market Size (2019-2030)
6.2 North America Cancer Hormone Therapy Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cancer Hormone Therapy Drugs Market Size by Country (2019-2024)
6.4 North America Cancer Hormone Therapy Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cancer Hormone Therapy Drugs Market Size (2019-2030)
7.2 Europe Cancer Hormone Therapy Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cancer Hormone Therapy Drugs Market Size by Country (2019-2024)
7.4 Europe Cancer Hormone Therapy Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Hormone Therapy Drugs Market Size (2019-2030)
8.2 Asia-Pacific Cancer Hormone Therapy Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cancer Hormone Therapy Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Cancer Hormone Therapy Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cancer Hormone Therapy Drugs Market Size (2019-2030)
9.2 Latin America Cancer Hormone Therapy Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cancer Hormone Therapy Drugs Market Size by Country (2019-2024)
9.4 Latin America Cancer Hormone Therapy Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Hormone Therapy Drugs Market Size (2019-2030)
10.2 Middle East & Africa Cancer Hormone Therapy Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cancer Hormone Therapy Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Cancer Hormone Therapy Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Cancer Hormone Therapy Drugs Introduction
11.1.4 Roche Revenue in Cancer Hormone Therapy Drugs Business (2019-2024)
11.1.5 Roche Recent Development
11.2 Amgen
11.2.1 Amgen Company Detail
11.2.2 Amgen Business Overview
11.2.3 Amgen Cancer Hormone Therapy Drugs Introduction
11.2.4 Amgen Revenue in Cancer Hormone Therapy Drugs Business (2019-2024)
11.2.5 Amgen Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Cancer Hormone Therapy Drugs Introduction
11.3.4 Pfizer Revenue in Cancer Hormone Therapy Drugs Business (2019-2024)
11.3.5 Pfizer Recent Development
11.4 Teva
11.4.1 Teva Company Detail
11.4.2 Teva Business Overview
11.4.3 Teva Cancer Hormone Therapy Drugs Introduction
11.4.4 Teva Revenue in Cancer Hormone Therapy Drugs Business (2019-2024)
11.4.5 Teva Recent Development
11.5 Takeda
11.5.1 Takeda Company Detail
11.5.2 Takeda Business Overview
11.5.3 Takeda Cancer Hormone Therapy Drugs Introduction
11.5.4 Takeda Revenue in Cancer Hormone Therapy Drugs Business (2019-2024)
11.5.5 Takeda Recent Development
11.6 Samyang Biopharmaceuticals
11.6.1 Samyang Biopharmaceuticals Company Detail
11.6.2 Samyang Biopharmaceuticals Business Overview
11.6.3 Samyang Biopharmaceuticals Cancer Hormone Therapy Drugs Introduction
11.6.4 Samyang Biopharmaceuticals Revenue in Cancer Hormone Therapy Drugs Business (2019-2024)
11.6.5 Samyang Biopharmaceuticals Recent Development
11.7 Tolmar
11.7.1 Tolmar Company Detail
11.7.2 Tolmar Business Overview
11.7.3 Tolmar Cancer Hormone Therapy Drugs Introduction
11.7.4 Tolmar Revenue in Cancer Hormone Therapy Drugs Business (2019-2024)
11.7.5 Tolmar Recent Development
11.8 AstraZeneca
11.8.1 AstraZeneca Company Detail
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Cancer Hormone Therapy Drugs Introduction
11.8.4 AstraZeneca Revenue in Cancer Hormone Therapy Drugs Business (2019-2024)
11.8.5 AstraZeneca Recent Development
11.9 Novartis
11.9.1 Novartis Company Detail
11.9.2 Novartis Business Overview
11.9.3 Novartis Cancer Hormone Therapy Drugs Introduction
11.9.4 Novartis Revenue in Cancer Hormone Therapy Drugs Business (2019-2024)
11.9.5 Novartis Recent Development
11.10 Aspen
11.10.1 Aspen Company Detail
11.10.2 Aspen Business Overview
11.10.3 Aspen Cancer Hormone Therapy Drugs Introduction
11.10.4 Aspen Revenue in Cancer Hormone Therapy Drugs Business (2019-2024)
11.10.5 Aspen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Hormone Therapy Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Tamoxifen
1.2.3 Aromatase Inhibitors
1.2.4 Antiandrogens
1.2.5 Androgen Synthesis Inhibitors
1.2.6 Other
1.3 Market by Application
1.3.1 Global Cancer Hormone Therapy Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Breast Cancer
1.3.3 Prostate Cancer
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Hormone Therapy Drugs Market Perspective (2019-2030)
2.2 Cancer Hormone Therapy Drugs Growth Trends by Region
2.2.1 Global Cancer Hormone Therapy Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cancer Hormone Therapy Drugs Historic Market Size by Region (2019-2024)
2.2.3 Cancer Hormone Therapy Drugs Forecasted Market Size by Region (2025-2030)
2.3 Cancer Hormone Therapy Drugs Market Dynamics
2.3.1 Cancer Hormone Therapy Drugs Industry Trends
2.3.2 Cancer Hormone Therapy Drugs Market Drivers
2.3.3 Cancer Hormone Therapy Drugs Market Challenges
2.3.4 Cancer Hormone Therapy Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Hormone Therapy Drugs Players by Revenue
3.1.1 Global Top Cancer Hormone Therapy Drugs Players by Revenue (2019-2024)
3.1.2 Global Cancer Hormone Therapy Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Cancer Hormone Therapy Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cancer Hormone Therapy Drugs Revenue
3.4 Global Cancer Hormone Therapy Drugs Market Concentration Ratio
3.4.1 Global Cancer Hormone Therapy Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Hormone Therapy Drugs Revenue in 2023
3.5 Cancer Hormone Therapy Drugs Key Players Head office and Area Served
3.6 Key Players Cancer Hormone Therapy Drugs Product Solution and Service
3.7 Date of Enter into Cancer Hormone Therapy Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Hormone Therapy Drugs Breakdown Data by Type
4.1 Global Cancer Hormone Therapy Drugs Historic Market Size by Type (2019-2024)
4.2 Global Cancer Hormone Therapy Drugs Forecasted Market Size by Type (2025-2030)
5 Cancer Hormone Therapy Drugs Breakdown Data by Application
5.1 Global Cancer Hormone Therapy Drugs Historic Market Size by Application (2019-2024)
5.2 Global Cancer Hormone Therapy Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cancer Hormone Therapy Drugs Market Size (2019-2030)
6.2 North America Cancer Hormone Therapy Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cancer Hormone Therapy Drugs Market Size by Country (2019-2024)
6.4 North America Cancer Hormone Therapy Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cancer Hormone Therapy Drugs Market Size (2019-2030)
7.2 Europe Cancer Hormone Therapy Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cancer Hormone Therapy Drugs Market Size by Country (2019-2024)
7.4 Europe Cancer Hormone Therapy Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Hormone Therapy Drugs Market Size (2019-2030)
8.2 Asia-Pacific Cancer Hormone Therapy Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cancer Hormone Therapy Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Cancer Hormone Therapy Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cancer Hormone Therapy Drugs Market Size (2019-2030)
9.2 Latin America Cancer Hormone Therapy Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cancer Hormone Therapy Drugs Market Size by Country (2019-2024)
9.4 Latin America Cancer Hormone Therapy Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Hormone Therapy Drugs Market Size (2019-2030)
10.2 Middle East & Africa Cancer Hormone Therapy Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cancer Hormone Therapy Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Cancer Hormone Therapy Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Cancer Hormone Therapy Drugs Introduction
11.1.4 Roche Revenue in Cancer Hormone Therapy Drugs Business (2019-2024)
11.1.5 Roche Recent Development
11.2 Amgen
11.2.1 Amgen Company Detail
11.2.2 Amgen Business Overview
11.2.3 Amgen Cancer Hormone Therapy Drugs Introduction
11.2.4 Amgen Revenue in Cancer Hormone Therapy Drugs Business (2019-2024)
11.2.5 Amgen Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Cancer Hormone Therapy Drugs Introduction
11.3.4 Pfizer Revenue in Cancer Hormone Therapy Drugs Business (2019-2024)
11.3.5 Pfizer Recent Development
11.4 Teva
11.4.1 Teva Company Detail
11.4.2 Teva Business Overview
11.4.3 Teva Cancer Hormone Therapy Drugs Introduction
11.4.4 Teva Revenue in Cancer Hormone Therapy Drugs Business (2019-2024)
11.4.5 Teva Recent Development
11.5 Takeda
11.5.1 Takeda Company Detail
11.5.2 Takeda Business Overview
11.5.3 Takeda Cancer Hormone Therapy Drugs Introduction
11.5.4 Takeda Revenue in Cancer Hormone Therapy Drugs Business (2019-2024)
11.5.5 Takeda Recent Development
11.6 Samyang Biopharmaceuticals
11.6.1 Samyang Biopharmaceuticals Company Detail
11.6.2 Samyang Biopharmaceuticals Business Overview
11.6.3 Samyang Biopharmaceuticals Cancer Hormone Therapy Drugs Introduction
11.6.4 Samyang Biopharmaceuticals Revenue in Cancer Hormone Therapy Drugs Business (2019-2024)
11.6.5 Samyang Biopharmaceuticals Recent Development
11.7 Tolmar
11.7.1 Tolmar Company Detail
11.7.2 Tolmar Business Overview
11.7.3 Tolmar Cancer Hormone Therapy Drugs Introduction
11.7.4 Tolmar Revenue in Cancer Hormone Therapy Drugs Business (2019-2024)
11.7.5 Tolmar Recent Development
11.8 AstraZeneca
11.8.1 AstraZeneca Company Detail
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Cancer Hormone Therapy Drugs Introduction
11.8.4 AstraZeneca Revenue in Cancer Hormone Therapy Drugs Business (2019-2024)
11.8.5 AstraZeneca Recent Development
11.9 Novartis
11.9.1 Novartis Company Detail
11.9.2 Novartis Business Overview
11.9.3 Novartis Cancer Hormone Therapy Drugs Introduction
11.9.4 Novartis Revenue in Cancer Hormone Therapy Drugs Business (2019-2024)
11.9.5 Novartis Recent Development
11.10 Aspen
11.10.1 Aspen Company Detail
11.10.2 Aspen Business Overview
11.10.3 Aspen Cancer Hormone Therapy Drugs Introduction
11.10.4 Aspen Revenue in Cancer Hormone Therapy Drugs Business (2019-2024)
11.10.5 Aspen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Cancer Hormone Therapy Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Tamoxifen
Table 3. Key Players of Aromatase Inhibitors
Table 4. Key Players of Antiandrogens
Table 5. Key Players of Androgen Synthesis Inhibitors
Table 6. Key Players of Other
Table 7. Global Cancer Hormone Therapy Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Cancer Hormone Therapy Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Cancer Hormone Therapy Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Cancer Hormone Therapy Drugs Market Share by Region (2019-2024)
Table 11. Global Cancer Hormone Therapy Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Cancer Hormone Therapy Drugs Market Share by Region (2025-2030)
Table 13. Cancer Hormone Therapy Drugs Market Trends
Table 14. Cancer Hormone Therapy Drugs Market Drivers
Table 15. Cancer Hormone Therapy Drugs Market Challenges
Table 16. Cancer Hormone Therapy Drugs Market Restraints
Table 17. Global Cancer Hormone Therapy Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Cancer Hormone Therapy Drugs Market Share by Players (2019-2024)
Table 19. Global Top Cancer Hormone Therapy Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Hormone Therapy Drugs as of 2023)
Table 20. Ranking of Global Top Cancer Hormone Therapy Drugs Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Cancer Hormone Therapy Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Cancer Hormone Therapy Drugs Product Solution and Service
Table 24. Date of Enter into Cancer Hormone Therapy Drugs Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Cancer Hormone Therapy Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Cancer Hormone Therapy Drugs Revenue Market Share by Type (2019-2024)
Table 28. Global Cancer Hormone Therapy Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Cancer Hormone Therapy Drugs Revenue Market Share by Type (2025-2030)
Table 30. Global Cancer Hormone Therapy Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Cancer Hormone Therapy Drugs Revenue Market Share by Application (2019-2024)
Table 32. Global Cancer Hormone Therapy Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Cancer Hormone Therapy Drugs Revenue Market Share by Application (2025-2030)
Table 34. North America Cancer Hormone Therapy Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Cancer Hormone Therapy Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Cancer Hormone Therapy Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Cancer Hormone Therapy Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Cancer Hormone Therapy Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Cancer Hormone Therapy Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Cancer Hormone Therapy Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Cancer Hormone Therapy Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Cancer Hormone Therapy Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Cancer Hormone Therapy Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Cancer Hormone Therapy Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Cancer Hormone Therapy Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Cancer Hormone Therapy Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Cancer Hormone Therapy Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Cancer Hormone Therapy Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 49. Roche Company Detail
Table 50. Roche Business Overview
Table 51. Roche Cancer Hormone Therapy Drugs Product
Table 52. Roche Revenue in Cancer Hormone Therapy Drugs Business (2019-2024) & (US$ Million)
Table 53. Roche Recent Development
Table 54. Amgen Company Detail
Table 55. Amgen Business Overview
Table 56. Amgen Cancer Hormone Therapy Drugs Product
Table 57. Amgen Revenue in Cancer Hormone Therapy Drugs Business (2019-2024) & (US$ Million)
Table 58. Amgen Recent Development
Table 59. Pfizer Company Detail
Table 60. Pfizer Business Overview
Table 61. Pfizer Cancer Hormone Therapy Drugs Product
Table 62. Pfizer Revenue in Cancer Hormone Therapy Drugs Business (2019-2024) & (US$ Million)
Table 63. Pfizer Recent Development
Table 64. Teva Company Detail
Table 65. Teva Business Overview
Table 66. Teva Cancer Hormone Therapy Drugs Product
Table 67. Teva Revenue in Cancer Hormone Therapy Drugs Business (2019-2024) & (US$ Million)
Table 68. Teva Recent Development
Table 69. Takeda Company Detail
Table 70. Takeda Business Overview
Table 71. Takeda Cancer Hormone Therapy Drugs Product
Table 72. Takeda Revenue in Cancer Hormone Therapy Drugs Business (2019-2024) & (US$ Million)
Table 73. Takeda Recent Development
Table 74. Samyang Biopharmaceuticals Company Detail
Table 75. Samyang Biopharmaceuticals Business Overview
Table 76. Samyang Biopharmaceuticals Cancer Hormone Therapy Drugs Product
Table 77. Samyang Biopharmaceuticals Revenue in Cancer Hormone Therapy Drugs Business (2019-2024) & (US$ Million)
Table 78. Samyang Biopharmaceuticals Recent Development
Table 79. Tolmar Company Detail
Table 80. Tolmar Business Overview
Table 81. Tolmar Cancer Hormone Therapy Drugs Product
Table 82. Tolmar Revenue in Cancer Hormone Therapy Drugs Business (2019-2024) & (US$ Million)
Table 83. Tolmar Recent Development
Table 84. AstraZeneca Company Detail
Table 85. AstraZeneca Business Overview
Table 86. AstraZeneca Cancer Hormone Therapy Drugs Product
Table 87. AstraZeneca Revenue in Cancer Hormone Therapy Drugs Business (2019-2024) & (US$ Million)
Table 88. AstraZeneca Recent Development
Table 89. Novartis Company Detail
Table 90. Novartis Business Overview
Table 91. Novartis Cancer Hormone Therapy Drugs Product
Table 92. Novartis Revenue in Cancer Hormone Therapy Drugs Business (2019-2024) & (US$ Million)
Table 93. Novartis Recent Development
Table 94. Aspen Company Detail
Table 95. Aspen Business Overview
Table 96. Aspen Cancer Hormone Therapy Drugs Product
Table 97. Aspen Revenue in Cancer Hormone Therapy Drugs Business (2019-2024) & (US$ Million)
Table 98. Aspen Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Hormone Therapy Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Cancer Hormone Therapy Drugs Market Share by Type: 2023 VS 2030
Figure 3. Tamoxifen Features
Figure 4. Aromatase Inhibitors Features
Figure 5. Antiandrogens Features
Figure 6. Androgen Synthesis Inhibitors Features
Figure 7. Other Features
Figure 8. Global Cancer Hormone Therapy Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Cancer Hormone Therapy Drugs Market Share by Application: 2023 VS 2030
Figure 10. Breast Cancer Case Studies
Figure 11. Prostate Cancer Case Studies
Figure 12. Cancer Hormone Therapy Drugs Report Years Considered
Figure 13. Global Cancer Hormone Therapy Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Cancer Hormone Therapy Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Cancer Hormone Therapy Drugs Market Share by Region: 2023 VS 2030
Figure 16. Global Cancer Hormone Therapy Drugs Market Share by Players in 2023
Figure 17. Global Top Cancer Hormone Therapy Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Hormone Therapy Drugs as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Cancer Hormone Therapy Drugs Revenue in 2023
Figure 19. North America Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Cancer Hormone Therapy Drugs Market Share by Country (2019-2030)
Figure 21. United States Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Cancer Hormone Therapy Drugs Market Share by Country (2019-2030)
Figure 25. Germany Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Cancer Hormone Therapy Drugs Market Share by Region (2019-2030)
Figure 33. China Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Cancer Hormone Therapy Drugs Market Share by Country (2019-2030)
Figure 41. Mexico Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Cancer Hormone Therapy Drugs Market Share by Country (2019-2030)
Figure 45. Turkey Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Roche Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2019-2024)
Figure 48. Amgen Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2019-2024)
Figure 49. Pfizer Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2019-2024)
Figure 50. Teva Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2019-2024)
Figure 51. Takeda Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2019-2024)
Figure 52. Samyang Biopharmaceuticals Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2019-2024)
Figure 53. Tolmar Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2019-2024)
Figure 54. AstraZeneca Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2019-2024)
Figure 55. Novartis Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2019-2024)
Figure 56. Aspen Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2019-2024)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Table 1. Global Cancer Hormone Therapy Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Tamoxifen
Table 3. Key Players of Aromatase Inhibitors
Table 4. Key Players of Antiandrogens
Table 5. Key Players of Androgen Synthesis Inhibitors
Table 6. Key Players of Other
Table 7. Global Cancer Hormone Therapy Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Cancer Hormone Therapy Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Cancer Hormone Therapy Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Cancer Hormone Therapy Drugs Market Share by Region (2019-2024)
Table 11. Global Cancer Hormone Therapy Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Cancer Hormone Therapy Drugs Market Share by Region (2025-2030)
Table 13. Cancer Hormone Therapy Drugs Market Trends
Table 14. Cancer Hormone Therapy Drugs Market Drivers
Table 15. Cancer Hormone Therapy Drugs Market Challenges
Table 16. Cancer Hormone Therapy Drugs Market Restraints
Table 17. Global Cancer Hormone Therapy Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Cancer Hormone Therapy Drugs Market Share by Players (2019-2024)
Table 19. Global Top Cancer Hormone Therapy Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Hormone Therapy Drugs as of 2023)
Table 20. Ranking of Global Top Cancer Hormone Therapy Drugs Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Cancer Hormone Therapy Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Cancer Hormone Therapy Drugs Product Solution and Service
Table 24. Date of Enter into Cancer Hormone Therapy Drugs Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Cancer Hormone Therapy Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Cancer Hormone Therapy Drugs Revenue Market Share by Type (2019-2024)
Table 28. Global Cancer Hormone Therapy Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Cancer Hormone Therapy Drugs Revenue Market Share by Type (2025-2030)
Table 30. Global Cancer Hormone Therapy Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Cancer Hormone Therapy Drugs Revenue Market Share by Application (2019-2024)
Table 32. Global Cancer Hormone Therapy Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Cancer Hormone Therapy Drugs Revenue Market Share by Application (2025-2030)
Table 34. North America Cancer Hormone Therapy Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Cancer Hormone Therapy Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Cancer Hormone Therapy Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Cancer Hormone Therapy Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Cancer Hormone Therapy Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Cancer Hormone Therapy Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Cancer Hormone Therapy Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Cancer Hormone Therapy Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Cancer Hormone Therapy Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Cancer Hormone Therapy Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Cancer Hormone Therapy Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Cancer Hormone Therapy Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Cancer Hormone Therapy Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Cancer Hormone Therapy Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Cancer Hormone Therapy Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 49. Roche Company Detail
Table 50. Roche Business Overview
Table 51. Roche Cancer Hormone Therapy Drugs Product
Table 52. Roche Revenue in Cancer Hormone Therapy Drugs Business (2019-2024) & (US$ Million)
Table 53. Roche Recent Development
Table 54. Amgen Company Detail
Table 55. Amgen Business Overview
Table 56. Amgen Cancer Hormone Therapy Drugs Product
Table 57. Amgen Revenue in Cancer Hormone Therapy Drugs Business (2019-2024) & (US$ Million)
Table 58. Amgen Recent Development
Table 59. Pfizer Company Detail
Table 60. Pfizer Business Overview
Table 61. Pfizer Cancer Hormone Therapy Drugs Product
Table 62. Pfizer Revenue in Cancer Hormone Therapy Drugs Business (2019-2024) & (US$ Million)
Table 63. Pfizer Recent Development
Table 64. Teva Company Detail
Table 65. Teva Business Overview
Table 66. Teva Cancer Hormone Therapy Drugs Product
Table 67. Teva Revenue in Cancer Hormone Therapy Drugs Business (2019-2024) & (US$ Million)
Table 68. Teva Recent Development
Table 69. Takeda Company Detail
Table 70. Takeda Business Overview
Table 71. Takeda Cancer Hormone Therapy Drugs Product
Table 72. Takeda Revenue in Cancer Hormone Therapy Drugs Business (2019-2024) & (US$ Million)
Table 73. Takeda Recent Development
Table 74. Samyang Biopharmaceuticals Company Detail
Table 75. Samyang Biopharmaceuticals Business Overview
Table 76. Samyang Biopharmaceuticals Cancer Hormone Therapy Drugs Product
Table 77. Samyang Biopharmaceuticals Revenue in Cancer Hormone Therapy Drugs Business (2019-2024) & (US$ Million)
Table 78. Samyang Biopharmaceuticals Recent Development
Table 79. Tolmar Company Detail
Table 80. Tolmar Business Overview
Table 81. Tolmar Cancer Hormone Therapy Drugs Product
Table 82. Tolmar Revenue in Cancer Hormone Therapy Drugs Business (2019-2024) & (US$ Million)
Table 83. Tolmar Recent Development
Table 84. AstraZeneca Company Detail
Table 85. AstraZeneca Business Overview
Table 86. AstraZeneca Cancer Hormone Therapy Drugs Product
Table 87. AstraZeneca Revenue in Cancer Hormone Therapy Drugs Business (2019-2024) & (US$ Million)
Table 88. AstraZeneca Recent Development
Table 89. Novartis Company Detail
Table 90. Novartis Business Overview
Table 91. Novartis Cancer Hormone Therapy Drugs Product
Table 92. Novartis Revenue in Cancer Hormone Therapy Drugs Business (2019-2024) & (US$ Million)
Table 93. Novartis Recent Development
Table 94. Aspen Company Detail
Table 95. Aspen Business Overview
Table 96. Aspen Cancer Hormone Therapy Drugs Product
Table 97. Aspen Revenue in Cancer Hormone Therapy Drugs Business (2019-2024) & (US$ Million)
Table 98. Aspen Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Hormone Therapy Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Cancer Hormone Therapy Drugs Market Share by Type: 2023 VS 2030
Figure 3. Tamoxifen Features
Figure 4. Aromatase Inhibitors Features
Figure 5. Antiandrogens Features
Figure 6. Androgen Synthesis Inhibitors Features
Figure 7. Other Features
Figure 8. Global Cancer Hormone Therapy Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Cancer Hormone Therapy Drugs Market Share by Application: 2023 VS 2030
Figure 10. Breast Cancer Case Studies
Figure 11. Prostate Cancer Case Studies
Figure 12. Cancer Hormone Therapy Drugs Report Years Considered
Figure 13. Global Cancer Hormone Therapy Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Cancer Hormone Therapy Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Cancer Hormone Therapy Drugs Market Share by Region: 2023 VS 2030
Figure 16. Global Cancer Hormone Therapy Drugs Market Share by Players in 2023
Figure 17. Global Top Cancer Hormone Therapy Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Hormone Therapy Drugs as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Cancer Hormone Therapy Drugs Revenue in 2023
Figure 19. North America Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Cancer Hormone Therapy Drugs Market Share by Country (2019-2030)
Figure 21. United States Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Cancer Hormone Therapy Drugs Market Share by Country (2019-2030)
Figure 25. Germany Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Cancer Hormone Therapy Drugs Market Share by Region (2019-2030)
Figure 33. China Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Cancer Hormone Therapy Drugs Market Share by Country (2019-2030)
Figure 41. Mexico Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Cancer Hormone Therapy Drugs Market Share by Country (2019-2030)
Figure 45. Turkey Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Cancer Hormone Therapy Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Roche Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2019-2024)
Figure 48. Amgen Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2019-2024)
Figure 49. Pfizer Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2019-2024)
Figure 50. Teva Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2019-2024)
Figure 51. Takeda Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2019-2024)
Figure 52. Samyang Biopharmaceuticals Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2019-2024)
Figure 53. Tolmar Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2019-2024)
Figure 54. AstraZeneca Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2019-2024)
Figure 55. Novartis Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2019-2024)
Figure 56. Aspen Revenue Growth Rate in Cancer Hormone Therapy Drugs Business (2019-2024)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Paint Leveling Agent Market Insights, Forecast to 2030
Dec 22, 24
Global Paint Adhesion Promoters Market Insights, Forecast to 2030
Dec 22, 24
Global Paint Rheological Additives Market Insights, Forecast to 2030
Dec 22, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232